Sleep Aids

Increased levels of uncertainty and fear caused stress and anxiety during the Coronavirus (COVID-19) pandemic and led to strong retail volume and current value sales growth in sleep aids in 2020 and 2021. This left the market size and value sales at…

Sleep aids has been registering dynamic retail volume growth in Germany, continuing the positive trend established over the review period. Even prior to the emergence of the pandemic, sleep disorders had been increasing in Germany, due to the…

Sleep aids is one of the smallest consumer health product areas in Egypt but has witnessed a strong period of growth in recent years with this continuing in 2022. Regular users of sleep aids are typically those suffering from insomnia which help them…

Having exhibited a double-digit decline during 2021, retail constant value sales (2020 prices) of sleep aids rebounded strongly in 2022 — rising well above their 2020 level. A spike in COVID-19 cases played a role in this, as insomnia is one of its…

In 2022, retail sales of sleep aids registered dynamic growth in current value terms, continuing the positive trend established during the review period. Even before the outbreak of COVID-19 pandemic, sleep disorders had been increasing in Portugal,…

Sleep problems and insomnia have become increasingly prevalent in China, especially among the younger population, due to work-related stress, anxiety, and the constant use of digital devices. The onset of the pandemic has exacerbated the problem.…

In light of the unprecedented nature of the pandemic, the subject of immunity has been a topic of great interest in the consumer health industry. Increasing numbers of pharmaceutical companies have been creating vaccines, including French…

The problem of sleep disorders in Poland is widespread, was already growing before the pandemic, and was further enhanced by the time of COVID-19. According to research, almost half of Polish consumers suffer from various sleep disorders. The problem…

Peruvians are still suffering from stress related to the COVID-19 pandemic on top of the current economic crisis, which has only raised anxiety further among Peruvian adults and its youth. Indeed, it is estimated that at least half of parents and…

In October 2021, melatonin, popularly known as the “sleep hormone”, was authorised in Brazil by ANVISA, the Brazilian health agency. This substance was approved as a food supplement with a daily intake of 0.21mg. In addition, the product’s label or…

Sleep aids recorded double-digit growth in current value terms in 2020 and 2021, but the category is set to see more stable growth in 2022, albeit remaining strong. The consumption of sleep aids increased in the first year of the COVID-19 pandemic…

Demand for sleep aids in Ireland surged in 2020 after more people started to suffer from insomnia and similar problems due to heightened levels of stress and anxiety resulting from the unprecedented economic and societal disruption that accompanied…

Sleep aids is expected to register moderate current value growth and a slight increase in volume sales. The war in Ukraine is pushing up retail prices, due to the energy crisis caused by the conflict. While Danish people are much less concerned about…

The global Coronavirus (COVID-19) pandemic has contributed to an increase in stress levels and anxiety, leading to more people suffering from disruption to their sleep. The demand for sleep aids spiked from 2020 onwards, and further strong retail…

Mental wellbeing, having a healthy immune system, feeling good and getting enough sleep are the top factors selected by Colombian consumers when defining what being in good health means to them, according to Euromonitor International’s Voice of the…

One would have thought that the market for sleep aids would struggle in 2022, after two years of double-digit value growth during the COVID-19 crisis. Consumers’ stress levels were high during the pandemic, leading to increased anxiety and insomnia.…

Sleep aids continues to grow in Sweden, with demand supported by sleep issues caused by high levels of general stress, the demands of working life and, in the last couple of years, the significant impact of the COVID-19 crisis and the Russian…

Retail value sales of sleep aids remain negligible in Thailand in 2022. According to the FDA, sleep aids can be classified into two categories: Psychotropic drug (with psychotropic substance); and dangerous drug (may be dispensed by first-grade…

Sleeps aids is a very small product area in Taiwan in terms of value sales with many insomnia sufferers preferring to try more natural methods or dietary supplements to aid restfulness. However, the pandemic and its subsequent stresses has led to…

Sleep aids remains highly dynamic in France in 2022. As lifestyles get more and more hectic with intensified workloads and increased late-night screen times, sleep quality among French consumers is getting notably poorer. According to the National…